On the synthesis of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane

被引:37
作者
Jagadish, Bhumasamudram [1 ]
Brickert-Albrecht, Gayle L. [1 ]
Nichol, Gary S. [1 ]
Mash, Eugene A. [1 ]
Raghunand, Natarajan [2 ]
机构
[1] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA
[2] Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Synthesis; DOTA; DO3A; Contrast agent; MRI; X-ray crystallography; MRI CONTRAST AGENTS; DESIGN; COMPLEXES; DOTA; DERIVATIVES;
D O I
10.1016/j.tetlet.2010.10.074
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane is widely used as an intermediate in the preparation of medically important DO3A and DOTA metal chelators. Despite its commercial availability and importance, the literature describing the preparation and properties of the free base is limited and sometimes unclear. We present herein an efficient synthesis of the hydrobromide salt of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane, characterize this compound spectroscopically and by X-ray crystallographic analysis, describe its simple conversion to the corresponding free base, characterize this compound spectroscopically and by X-ray crystallographic analysis, and make observations on the reactivity of this interesting and useful compound. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2058 / 2061
页数:4
相关论文
共 26 条
[1]  
Axelsson H. O., 2006, Patent No. [WO 2006/112723 Al, 2006112723, 2006/112723]
[2]   Bifunctional ligands based on the DOTA-monoamide cage [J].
Barge, Alessandro ;
Tei, Lorenzo ;
Upadhyaya, Dharita ;
Fedeli, Franco ;
Beltrami, Lorena ;
Stefania, Rachele ;
Aime, Silvio ;
Cravotto, Giancarlo .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2008, 6 (07) :1176-1184
[3]  
BERG A, Patent No. 5198208
[4]   Smart MR Imaging Agents Relevant to Potential Neurologic Applications [J].
Bonnet, C. S. ;
Toth, E. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2010, 31 (03) :401-409
[5]   Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications [J].
Caravan, P ;
Ellison, JJ ;
McMurry, TJ ;
Lauffer, RB .
CHEMICAL REVIEWS, 1999, 99 (09) :2293-2352
[6]   Strategies for increasing the sensitivity of gadolinium based MRI contrast agents [J].
Caravan, Peter .
CHEMICAL SOCIETY REVIEWS, 2006, 35 (06) :512-523
[7]   Synthesis and biological evaluation of a novel decadentate ligand DEPA [J].
Chong, Hyun-Soon ;
Lim, Sooyoun ;
Baidoo, Kwamena E. ;
Milenic, Diane E. ;
Ma, Xiang ;
Jia, Fang ;
Song, Hyun A. ;
Brechbiel, Martin W. ;
Lewis, Michael R. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (21) :5792-5795
[8]   Long wavelength sensitizers for europium(III) luminescence based on acridone derivatives [J].
Dadabhoy, A ;
Faulkner, S ;
Sammes, PG .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 2002, (02) :348-357
[9]   Gadolinium(III) complexes as MRI contrast agents:: ligand design and properties of the complexes [J].
Hermann, Petr ;
Kotek, Jan ;
Kubicek, Vojtech ;
Lukes, Ivan .
DALTON TRANSACTIONS, 2008, (23) :3027-3047
[10]  
HIMMELSBACH RJ, 1993, Patent No. 9302045